financetom
Business
financetom
/
Business
/
ATS Q1 Adjusted Earnings Fall Even as Revenue Advances
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
ATS Q1 Adjusted Earnings Fall Even as Revenue Advances
Aug 7, 2025 4:27 AM

07:06 AM EDT, 08/07/2025 (MT Newswires) -- ATS (ATS.TO) on Thursday reported lower first-quarter adjusted earnings despite higher revenue.

Adjusted operating earnings fell 8.8% to $78.6 million, or $0.41 per basic share, from $86.2 million, or $0.50 per basic share, in the prior year period. Analysts polled by FactSet had expected $0.44 per share.

Revenue rose 6.1% over the same period, to $736.7 million, beating the $712.20 million forecast. Revenue was boosted by contributions from acquired companies and foreign exchange impact.

"Today ATS reported our first quarter results for fiscal 2026, with revenue growth, including contributions from recent acquisitions, and adjusted earnings margins in line with our expectations," said Andrew Hider, chief executive officer. "These results reflect continued focus on our value drivers, the resilience of our business model, and the dedication of our global teams."

Hider departs the company today to pursue another leadership opportunity. Current Chief Financial Officer Ryan McLeod will assume the role of interim CEO.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Metsera shareholders vote for up to $10 billion acquisition by Pfizer
Metsera shareholders vote for up to $10 billion acquisition by Pfizer
Nov 13, 2025
Nov 13 (Reuters) - Metsera ( MTSR ) shareholders on Thursday approved Pfizer's ( PFE ) takeover offer worth up to $10 billion, as per preliminary count, allowing the U.S. pharmaceutical giant to gain a foothold in the lucrative obesity treatment market after a fierce bidding war with Wegovy-maker Novo Nordisk. The approval paves the way for Pfizer ( PFE...
Research Alert: CFRA Upgrades View To Buy From Hold On Shares Of Lowe's Companies, Inc.
Research Alert: CFRA Upgrades View To Buy From Hold On Shares Of Lowe's Companies, Inc.
Nov 13, 2025
09:30 AM EST, 11/13/2025 (MT Newswires) -- CFRA, an independent research provider, has provided MT Newswires with the following research alert. Analysts at CFRA have summarized their opinion as follows: Our 12-month target price of $290, up from $245, is 22x our FY 27 EPS view, a premium to the five-year P/E mean of 16.6x. We revise our FY 26...
Ideal Power Q3 net loss widens to $2.9 mln
Ideal Power Q3 net loss widens to $2.9 mln
Nov 13, 2025
Overview * Ideal Power ( IPWR ) Q3 net loss widens to $2.9 mln from $2.7 mln yr/yr * Operating expenses rose to $3.0 mln in Q3 due to higher R&D spending * Company secured Stellantis purchase order for B-TRAN devices targeting EV applications Outlook * Ideal Power ( IPWR ) expects to complete Stellantis deliverables next year * Company...
Israeli identity and security solutions firm SuperCom's Q3 revenue beats expectations
Israeli identity and security solutions firm SuperCom's Q3 revenue beats expectations
Nov 13, 2025
Overview * SuperCom ( SPCB ) Q3 revenue beats analyst expectations, despite a year-over-year decline * Company secured over 30 new EM contracts in the U.S. since mid-2024 Outlook * SuperCom ( SPCB ) did not provide specific financial guidance for future quarters or the full year Result Drivers * GROSS MARGIN EXPANSION - Co achieved higher gross margins, expanding...
Copyright 2023-2026 - www.financetom.com All Rights Reserved